Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150410
Status:
COMPLETED
Last Update Posted:
2008-10-31
First Post:
2005-09-06
Brief Title:
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea Metformin In Controlling Glucose
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A One-Year Open Randomized Parallel Three-Arm Study Comparing Exubera Insulin Dry Powder Pulmonary Inhaler vs Avandia Rosiglitazone Maleate as Add-On Therapy vs Exubera Substitution of Sulfonylurea in Patients With Type 2 Diabetes Poorly Controlled on Combination Sulfonylurea and Metformin Treatment
Status:
COMPLETED
Status Verified Date:
2008-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Whether a combination of three therapies - metformin and a sulfonylurea plus Exubera an investigational drug controls your diabetes at least as much as a triple combination therapy of metformin and a sulfonylurea plus Avandia a Food and Drug Administration FDA approved drug
Whether a combination of two therapies - metformin plus Exubera controls your diabetes at least as much as a as a triple combination therapy of metformin and a sulfonylurea plus Avandia
Whether a combination of two therapies - metformin plus Exubera controls your diabetes at least as much as a as a triple combination therapy of metformin and a sulfonylurea plus Avandia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None